BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zou ZQ, Wang L, Wang K, Yu JG. Innate immune targets of hepatitis B virus infection. World J Hepatol 2016; 8(17): 716-725 [PMID: 27330680 DOI: 10.4254/wjh.v8.i17.716]
URL: https://www.wjgnet.com/1007-9327/full/v8/i17/716.htm
Number Citing Articles
1
Jinfeng Liu, Jing Wang, Caijing Qi, Furong Cao, Zhen Tian, Dandan Guo, Taotao Yan, Qian Li, Shujuan Yang, JianJun Fu, Xianmei Tang, Xiaoni Kou, Na Liu, Zicheng Jiang, Yingren Zhao, Tianyan Chen. Baseline Hepatitis B Virus Titer Predicts Initial Postpartum Hepatic FlareJournal of Clinical Gastroenterology 2018; 52(10): 902 doi: 10.1097/MCG.0000000000000877
2
Manasa Suresh, Bin Li, Marta G. Murreddu, Severin O. Gudima, Stephan Menne. Involvement of Innate Immune Receptors in the Resolution of Acute Hepatitis B in WoodchucksFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.713420
3
Hassan A. Alhazmi, Asim Najmi, Sadique A. Javed, Shahnaz Sultana, Mohammed Al Bratty, Hafiz A. Makeen, Abdulkarim M. Meraya, Waquar Ahsan, Syam Mohan, Manal M. E. Taha, Asaad Khalid. Medicinal Plants and Isolated Molecules Demonstrating Immunomodulation Activity as Potential Alternative Therapies for Viral Diseases Including COVID-19Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.637553
4
Itaru Ozeki, Tomoaki Nakajima, Hirokazu Suii, Ryoji Tatsumi, Masakatsu Yamaguchi, Mutsuumi Kimura, Tomohiro Arakawa, Yasuaki Kuwata, Takumi Ohmura, Shuhei Hige, Yoshiyasu Karino, Joji Toyota. Analysis of hepatitis B surface antigen (HBsAg) using high‐sensitivity HBsAg assays in hepatitis B virus carriers in whom HBsAg seroclearance was confirmed by conventional assaysHepatology Research 2018; 48(3) doi: 10.1111/hepr.12979
5
Jodi Wong, Stephen Yiu Chuen Choi, Rongrong Liu, Eddie Xu, James Killam, Peter W. Gout, Yuzhuo Wang. Potential Therapies for Infectious Diseases Based on Targeting Immune Evasion Mechanisms That Pathogens Have in Common With Cancer CellsFrontiers in Cellular and Infection Microbiology 2019; 9 doi: 10.3389/fcimb.2019.00025
6
Ganesh Selvaraj Duraisamy, Dattatry Bhosale, Ivana Lipenská, Ivana Huvarova, Daniel Růžek, Marc P. Windisch, Andrew D. Miller. Advanced Therapeutics, Vaccinations, and Precision Medicine in the Treatment and Management of Chronic Hepatitis B Viral Infections; Where Are We and Where Are We Going?Viruses 2020; 12(9): 998 doi: 10.3390/v12090998
7
Hajar Chihab, Imane Zaidane, Abdellah Elhabazi, Fatima-Zahra Jadid, Raouia El Fihri, Mohcine Elmessaoudi-Idrissi, Mohammed Chair, Wafaa Badre, Mohamed Tahiri, Pascal Pineau, Isabelle Chemin, Sayeh Ezzikouri, Soumaya Benjelloun. Toll-like receptor 9 polymorphisms and Hepatitis B virus clearance in Moroccan chronic carriersGene 2019; 687: 212 doi: 10.1016/j.gene.2018.11.041
8
Mohadeseh Hasanpourghadi, Mikhail Novikov, Dakota Newman, ZhiQuan Xiang, Xiang Yang Zhou, Colin Magowan, Hildegund C. J. Ertl. Hepatitis B virus polymerase-specific T cell epitopes shift in a mouse model of chronic infectionVirology Journal 2021; 18(1) doi: 10.1186/s12985-021-01712-y
9
Muttiah Barathan, Behnaz Riazalhosseini, Thevambiga Iyadorai, Kumutha Malar Vellasamy, Jamuna Vadivelu, Li-Yen Chang, Ahmad Khusairy Zulpa, Marie Larsson, Esaki M. Shankar, Rosmawati Mohamed. Comparative expression of pro-inflammatory and apoptotic biosignatures in chronic HBV-infected patients with and without liver cirrhosisMicrobial Pathogenesis 2021; 161: 105231 doi: 10.1016/j.micpath.2021.105231